Skip to main content
SpringerLink
Log in

Frühansprechen auf Antidepressiva: die prognostische Bedeutung der Probetherapie

  • Conference paper
Therapieresistenz unter Antidepressiva-Behandlung

Part of the book series: Tropon-Symposium ((BAYERZNS,volume 5))

Zusammenfassung

Etwa ein Drittel der medikamentös behandelten depressiven Patienten spricht auf das erstverordnete Antidepressivum nicht an. Noch ungünstiger sieht es bei hospitalisierten depressiven Patienten aus: Von diesen zeigt nur etwa die Hälfte eine Besserung (Woggon 1979). Spricht ein Patient auf die erste antidepressive Behandlung nicht an, so sollte dies nicht als Therapieresistenz bezeichnet werden. Es ist zwar bisher nicht gelungen eine einheitliche Definition des Begriffes „Therapieresistenz“ herauszuarbeiten, am häufigsten wird aber folgende verwendet: Nichtansprechen auf zwei verschiedene Antidepressiva in adäquater Dosierung (entsprechend ≥150 mg Imipramin/Tag) und von adäquater Behandlungsdauer (≥4 Wochen).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amsterdam JD, Berwish NJ (1989) High dose Tanylcypromine therapy for refractory depression. Pharmacopsychiatry 22:21–25

    Article  PubMed  CAS  Google Scholar 

  • Angst J, Beck P, Boyer P, Bruinvels J, Engel H, Heimchen H, Hippius H, Lingjaerde O, Racagni G, Saletu B, Sedvall G, Silverstone JT, Stefanis CN, Stoll K, Woggon B (1989) Consensus conference on the methodology of clinical trials of antidepressants, Zurich, March 1988: Report of the Consensus Committee. Pharmacopsychiatry 22:3–7

    Article  Google Scholar 

  • Bridges PK (1983) ”... And a small dose of an antidepressant might help”. Br J Psychiatry 142:626–628

    Article  PubMed  CAS  Google Scholar 

  • Ceroni GB, Neri C, Pezzoli A (1984) Chronicity in major depression - a naturalistic prospective study. J Affect Dis 7:123–132

    Article  Google Scholar 

  • Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D (1987) Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 48:197–200

    PubMed  CAS  Google Scholar 

  • Fähndrich E, Haug HJ (1987) Die wahnhafte Depression - ein eigenständiges Krankheitsbild? In: 15. AGNP-Symposium Nürnberg, Abstracts, p 81ff

    Google Scholar 

  • Fairchild CJ, Rush AJ, Vasavada N, Giles DE, Khatami M (1986) Which depressions respond to placebo. Psychiatry Res 18:217–226

    Article  PubMed  CAS  Google Scholar 

  • Garvey MJ, Tollefson GD, Tuason VB (1986) Is chronic primary major depression a distinct depression subtype? Compr Psychiatry 27:446–448

    Article  PubMed  CAS  Google Scholar 

  • Guze BH, Baxter LR, Rego J (1987) Refractory depression treated with high doses of a monoamine oxidase inhibitor. J Clin Psychiatry 48:31–32

    PubMed  CAS  Google Scholar 

  • Haskel DS, DiMascio A, Prusoff B (1975) Rapidity of symptom reduction in depressions treated with Amitriptyline. J Nerv Ment Dis 160:24–33

    Article  Google Scholar 

  • Hordern A, Holt NF, Burt CG, Gordon WF (1963) Amitriptyline in depressive states. Phenomenology and prognostic considerations. Br J Psychiatry 109:815–825

    Article  PubMed  CAS  Google Scholar 

  • Johnson DAW (1981) Depression: treatment compliance in general practice. Acta Psychiatr Scand [Suppl 290] 63:447–453

    Article  Google Scholar 

  • Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond JRE (1987) The toming, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 17:297–309

    Article  PubMed  CAS  Google Scholar 

  • Keller MB, Klerman GL, Lavori PW, Fawcett JA, Coryell W, Endicott J (1982) Treatment received by depressed patients. JAMA 248:1848–1855

    Article  PubMed  CAS  Google Scholar 

  • Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RMA (1986) The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: A prospective follow-up. Am J Psychiatry 143:24–28

    PubMed  CAS  Google Scholar 

  • Kotin J, Post RM, Goodwin FK (1973) Drug treatment of depressed patients referred for hospitalization. Am J Psychiatry 130:1139–1141

    PubMed  CAS  Google Scholar 

  • Kuhn R (1957) Über die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355). Schweiz Med Wochenschr 87:1135–1140

    PubMed  CAS  Google Scholar 

  • Kupfer DJ, Frank E, Perel JM (1989) The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatry 46:771–775

    Article  PubMed  CAS  Google Scholar 

  • Lesse S (1960) The evaluation of imipramine hydrochloride in the ambulatory treatment of depressed patients. J Neuropsychiatr 1:246–252

    PubMed  CAS  Google Scholar 

  • Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF (1988) Antidepressant specificity in atypical depression. Arch Gen Psychiatry 45:129–137

    Article  PubMed  CAS  Google Scholar 

  • Michel K (1986) Suizide und Suizideversuche: Könnte der Arzt mehr tun? Schweiz Med Wochenschr 116:770–774

    PubMed  CAS  Google Scholar 

  • Modestin J (1985) Antidepressive therapy in depressed clinical suicides. Acta Psychiatr Scand 71:111–116

    Article  PubMed  CAS  Google Scholar 

  • Möller HJ, Fischer G, Zerssen D v (1987) Prediction of therapeutic response in acute treatment with antidepressants. Eur Arch Psychiatr Neurol Sci 236:349–357

    Article  Google Scholar 

  • Nelson JC, Mazure C, Quinlan DM, Jatlow PI (1984) Drug-responsive symptoms in melancholia. Arch Gen Psychiatry 41:663–668

    Article  PubMed  CAS  Google Scholar 

  • Nies A (1984) Differential response patterns to MAO inhibitors and tricyclics. J Clin Psychiatry 45:70–77

    PubMed  CAS  Google Scholar 

  • Overholser JC, Miller IW, Norman WH (1987) The course of depressive symptoms in suicidal vs. non- suicidal depressed inpatients. J Nerv Ment Dis 175:450–456

    Article  PubMed  CAS  Google Scholar 

  • Paykel ES, Hollyman JA, Freeling P, Sedgwick P (1988) Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Dis 14:83–95

    Article  PubMed  CAS  Google Scholar 

  • Paykel S, Prusoff BA (1973) Response set and observer set in the assessment of depressed patients. Psychol Med 3:209–216

    Article  PubMed  CAS  Google Scholar 

  • Quitkin FM (1985) The importance of dosage in prescribing antidepressants. Br J Psychiatry 147:593–597

    Article  PubMed  CAS  Google Scholar 

  • Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wagner SG (1988) Phenelzine versus Imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 145:306–311

    PubMed  CAS  Google Scholar 

  • Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wagner SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF (1989) Phenelzine and Imipramine in mood reactive depressives. Arch Gen Psychiatry 46:787–793

    Article  PubMed  CAS  Google Scholar 

  • Remick RA (1989) Treatment resistant depression. Psychiatric J Univ Ottawa 14:394–396

    CAS  Google Scholar 

  • Rose JT, Westhead TT (1967) Treatment of depression. A comparative trial of Imipramine and Desipramine. Br J Psychiatry 113:659–665

    Article  PubMed  CAS  Google Scholar 

  • Rush AJ, Hiser W, Giles DE (1987) A comparison of self-reported versus clinician-rated symptoms in depression. J Clin Psychiatry 48:246–248

    PubMed  CAS  Google Scholar 

  • Schatzberg AF, Cole JO, Cohen BM, Altesman RI, Sniffin CM (1983) Survey of depressed patients who have failed to respond to treatment. In: Davis JM, Maas JW (eds) The affective disorders. Am Psychiatr Press Inc, Washington DC, pp 73–86

    Google Scholar 

  • Schuckit MA, Feighner JP (1972) Safety of High-Dose Tricyclic Antidepressant Therapy. Am J Psychiatry 128:1456–1459

    PubMed  CAS  Google Scholar 

  • Small JG, Milstein V, Kellams JJ, Small IF (1981) Comparative onset of improvement in depressive symptomatology with drug treatment, electroconvulsive therapy, and placebo. J Clin Psychopharmacol 1/6 [Suppl]:62S-69S

    Article  Google Scholar 

  • Spear FG, Hall P, Stirland JD (1964) A comparison of subjective responses to Imipramine and Tranylcypromine. Br J Psychiatry 110:53–55

    Article  PubMed  CAS  Google Scholar 

  • Waldron J, Bates TJN (1965) The management of depression in hospital. A comparative trial of Desi- pramine and Imipramine. Br J Psychiatry 111:511–516

    Article  PubMed  CAS  Google Scholar 

  • Wittenborn JR, Kiremitci N (1975) A comparison of antidepressant medications in neurotic and psychotic patients. Arch Gen Psychiatry 32:1172–1176

    Article  PubMed  CAS  Google Scholar 

  • Woggon B (1979) Klinische Psychopharmakologie. In: Psychiatrische Universitätsklinik Zürich, Forschungsdirektion. Zehnjahresbericht 1969–1979, Zürich, pp 67–105

    Google Scholar 

  • Woggon B (1980) Veränderungen der psychopathologischen Symptomatik während 20-tägiger antidepressiver oder neuroleptischer Behandlung. Psychiatr Clin 13:150–164

    CAS  Google Scholar 

  • Woggon B (1983) Prognose der Psychopharmakotherapie. Enke, Stuttgart

    Google Scholar 

  • Woggon B, Angst J (1980) Psychopharmakotherapie. In: Kisker KP, Meyer JE, Müller C, Strömgren E (Hrsg) Psychiatrie der Gegenwart, Forschung und Praxis. Grundlagen und Methoden der Psychiatrie, Band I, 2 Aufl, Teil 2. Springer, Berlin Heidelberg New York Tokyo, pp 243–314

    Google Scholar 

  • Woggon B, Bosshart P, Meyer JW, Baumann P (1988) Mögliche Konsequenzen des Debrisoquin-Hy- droxylierungsdefektes für die Behandlung mit Psychopharmaka - Zusammenfassung mehrerer Schweizer Untersuchungen. In: Gross G, Huber G (Hrsg) Das ärztliche Gespräch, Band 44: Neuere pharmakopsychiatrische und neurochemische Ergebnisse der Psychosenforschung. 3. Hans Jörg Weitbrecht-Symposion, 20.02.1988, Bonn, Troponwerke, Köln, pp 79–86

    Google Scholar 

Download references

Authors
  1. B. Woggon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrie, Universitäts-Nervenklinik, Sigmund-Freud-Straße 25, D-5300, Bonn 1, Deutschland

    Hans-Jürgen Möller

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Woggon, B. (1990). Frühansprechen auf Antidepressiva: die prognostische Bedeutung der Probetherapie. In: Möller, HJ. (eds) Therapieresistenz unter Antidepressiva-Behandlung. Tropon-Symposium, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84236-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84236-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52765-7

  • Online ISBN: 978-3-642-84236-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation